The U.S. Food and Drug Administration is reviewing whether to change the warning label on hormone replacement therapy drugs used to treat menopause symptoms, a move many experts say is long overdue.
The U.S. Food and Drug Administration approved on Friday labeling changes for the blood cancer therapy of Johnson & Johnson and its partner Legend Biotech to include a warning for a potentially fatal ...
The Food and Drug Administration (FDA) will remove broad “black box” warning labels from hormone replacement therapy (HRT) for menopause. The action, announced Monday, follows a comprehensive review ...
The US Food and Drug Administration plans to make changes soon to the lengthy black box warning on many hormone replacement products for women with menopause symptoms, Commissioner Dr. Martin Makary ...
This is read by an automated voice. Please report any issues or inconsistencies here. The FDA is removing a 22-year-old warning label from hormone-based menopause drugs, saying newer evidence shows ...
Philadelphia — For years, Cathleen “Cat” Brown, a Philadelphia obstetrician and gynecologist, would listen to patients complaining of hot flashes, brain fog, and painful sex and prescribe estrogen as ...
The FDA approved a label change for Pfizer’s birth control injection Depo-Provera on Dec. 13, adding a warning about the risk of meningioma — a brain tumor — to two versions of the drug. The update ...
An FDA official told a room of Make America Healthy Again supporters Monday that the agency needs data to make any changes to psychiatric drug labels after hours of testimony about patient experiences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results